VERGANI, LODOVICA
 Distribuzione geografica
Continente #
NA - Nord America 2.830
EU - Europa 388
AS - Asia 334
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.554
Nazione #
US - Stati Uniti d'America 2.825
CN - Cina 233
SE - Svezia 96
FI - Finlandia 70
IT - Italia 62
VN - Vietnam 53
UA - Ucraina 52
DE - Germania 51
GB - Regno Unito 31
SG - Singapore 24
IN - India 15
HK - Hong Kong 9
FR - Francia 8
IE - Irlanda 8
RU - Federazione Russa 5
CA - Canada 4
CH - Svizzera 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
EU - Europa 1
PA - Panama 1
Totale 3.554
Città #
Fairfield 417
Chandler 306
Woodbridge 249
Jacksonville 218
Houston 198
Ashburn 192
Ann Arbor 184
Wilmington 156
Cambridge 144
Seattle 137
Princeton 80
Beijing 57
Dong Ket 53
Roxbury 52
Des Moines 42
Nanjing 37
Medford 36
San Diego 35
Boardman 33
Helsinki 24
Padova 24
Jinan 21
New York 19
Singapore 18
Guangzhou 14
Hebei 12
Nanchang 11
Norwalk 10
Tianjin 10
Shenyang 9
Changsha 8
Dublin 8
Milan 8
Haikou 6
Hong Kong 6
Jiaxing 6
Aprilia 5
London 5
Redwood City 5
Saint Petersburg 5
Hangzhou 4
Shanghai 4
Taiyuan 4
Cumming 3
Hefei 3
Mountain View 3
Paris 3
Sacramento 3
Zhengzhou 3
Auburn Hills 2
Bologna 2
Cugliate-Fabiasco 2
Fuzhou 2
Indiana 2
Kharkiv 2
Kilburn 2
Kunming 2
Lanzhou 2
Menlo Park 2
New Delhi 2
Ningbo 2
Redmond 2
Rome 2
Sabaudia 2
Venice 2
Wenzhou 2
Berlin 1
Bolton 1
Borås 1
Brendola 1
Brussels 1
Chandigarh 1
Chengdu 1
Chester 1
Chiswick 1
Chongqing 1
Curtarolo 1
Edinburgh 1
Graz 1
Hyderabad 1
Lake Forest 1
Langfang 1
Las Vegas 1
Laval 1
Miami Beach 1
Munich 1
Ogden 1
Orange 1
Panama City 1
Philadelphia 1
Phoenix 1
Pune 1
Rockville 1
San Mateo 1
Sarego 1
Sofia 1
Stockholm 1
São Paulo 1
Tappahannock 1
Toronto 1
Totale 2.958
Nome #
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet 184
null 171
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 152
Abnormal free radical homeostasis and oxphos activity in ALS muscle 119
Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts 113
Cultured muscle cells display defects of mitochondrial myopathy ameliorated by anti-oxidants 108
Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNA. 104
Energy matters: Mitochondrial proteomics for biomedicine 100
Dominant optic atrophy caused by a novel OPA1 mutation: Disruption of the mitochondrial network with preserved bioenergetics. 100
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. 98
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 97
Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. 95
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1 93
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 93
INHIBITION OF MITOCHONDRIAL FISSION FAVOURS MUTANT OVER WILD-TYPE MITOCHONDRIAL DNA 92
Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient 78
A pilot trial with clenbuterol in amyotrophic lateral sclerosis 77
Adult acid maltase deficiency: an open trial with albuterol and branched- chain aminoacids 76
Physiological responses in McArdle's patients during maximal aerobic exercise 73
The mitochondrial fission protein hFis1 requires the endoplasmic reticulum gateway to induce apoptosis 72
Energy status and ROS production in three RHO0 cell lines with different nuclear background 72
Biased incorporation of ribonucleotides on the mitochondrial L-strand accounts for apparent strand-asymmetric DNA replication. 71
The ALPINE–ALMA [C ii] Survey: Multiwavelength Ancillary Data and Basic Physical Measurements 69
Hypertrophic cardiomyopathy with mitochondrial myopathy. A new phenotype of complex II defect. 63
Clinical and pathological findings in families with X-linked spinal and bulbar muscular atrophy (Kennedy's disease). 62
Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissues 62
Overexpression of microRNA-206 in the skeletalmuscle from myotonic dystrophy type 1 patients 61
Hereditary protein C deficiency associated with riboflavin-responsive lipid storage myopathy 60
MITOCHONDRIAL PROTEINS IN RIBOFLAVIN-RESPONSIVE MYOPATIES 48
Functional and molecular responses to stress conditions in heteroplasmic MELAS 3243 RD cybrids. 48
Characterisation of undifferentiated and differentiated RD-cybrids, harbouring 3243 MELAS mutation 44
UV and Lyα luminosity functions of galaxies and star formation rate density at the end of HI reionization from the VIMOS UltraDeep Survey (VUDS) 44
Antioxidant defences and reactive oxygen species homeostasis in different human mitochondrial DNA-depleted cell lines. 42
Homeostasis of reactive oxygen species in mtDNA-depleted cell lines 40
Muscle histopatology in patients with X-linked bulbar and spinal muscular atrophy (Kennedy's disease) and female carriers. 40
Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies. 40
Alteration of mechanisms responsible for the homeostasis of mitochondrial flavin cofactors are correlated with adult lipid storage myopathies 39
Diagnosis and therapy of myophosphorylase deficiency: experience with a group of italian patients 38
Carnitine deficiency induced during hemodialysis and hyperlipidemia: Effect of replacement therapy 38
"Polyspecific anti-mitochondrion antibodies detect up- and down-regulated proteins in in toto muscle homogenates from MELAS patients 37
Polyspecific anti-Mitochondrion Antibodies for Proteomics on in toto Tissue Homogenates 37
Immobilized pH gradients with electrodic plateaus (and other unusual procedures for 2DE) 37
Antioxidant capacity in cybrids harbouring the three mtDNA mutations primarly associated with Leber’s (LHON) 36
The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic distrophy type 1 patients. 35
Riboflovin responsive myopathy: correlation between mitochondrial oxidative phosphorilation enzymes and mitochondrial flavocoenzyme homeostasis. 35
Functional and molecular responses to stress conditions in heteroplasmic MELAS (3243) RD cybrids. 35
Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissues 34
ROS HOMEOSTASIS AND ENERGY STATUS IN mtDNA DEPLETION 33
ANTIOXIDANT CAPACITY IN CYBRIDS HARBORING THE THREE MTDNA RELATED TO COMPLEX I MUTATIONS SUBUNITS AND PRIMARILY ASSOCIATED WITH LEBER'S (LHON) 32
Altered mitochondrial morphology after in vitro muscle differentiation in MELAS (A3243G) RD cybrids 31
Decreased fatty-acid beta-oxidation in riboflavin-responsive, multiple acylcoenzyme A dehydrogenase-deficient patients is associated with an increase in uncoupling protein-3 30
Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes 25
Clinical varieties of carnitine and carnitine palmitoyltransferase deficiency 21
Childhood encephalomyopathy with cytochrome c oxidase deficiency, ataxia, muscle wasting, and mental impairment 20
MODIFICAZIONI DELLE DIFESE ANTIOSSIDANTI IN CIBRIDI MELAS CON BACKGROUND NUCLEARE MUSCOLARE INDOTTE DAL DIFFERENZIAMENTO 14
Clinical varieties of carnitine and carnitine palmitoyltransferase deficiency 14
Totale 3.582
Categoria #
all - tutte 11.215
article - articoli 8.865
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 160
Totale 20.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201970 0 0 0 0 0 0 0 0 0 0 0 70
2019/2020732 97 20 18 43 63 52 61 70 58 157 62 31
2020/2021630 22 87 32 40 45 56 7 35 92 62 69 83
2021/2022657 8 66 85 62 71 48 12 60 34 7 53 151
2022/2023617 105 79 7 64 116 92 0 42 75 6 30 1
2023/2024235 8 49 30 17 23 42 14 9 8 9 26 0
Totale 3.582